381 related articles for article (PubMed ID: 6315763)
41. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.
Maton PN; O'Dorisio TM; Howe BA; McArthur KE; Howard JM; Cherner JA; Malarkey TB; Collen MJ; Gardner JD; Jensen RT
N Engl J Med; 1985 Jan; 312(1):17-21. PubMed ID: 2856888
[No Abstract] [Full Text] [Related]
42. Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like molecule.
Yiangou Y; Christofides ND; Blank MA; Yanaihara N; Tatemoto K; Bishop AE; Polak JM; Bloom SR
Gastroenterology; 1985 Sep; 89(3):516-24. PubMed ID: 3839480
[TBL] [Abstract][Full Text] [Related]
43. Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.
Devine BL; Carmichael HA; Russell RI; Joffe SN
Postgrad Med J; 1978 Aug; 54(634):566-70. PubMed ID: 215990
[TBL] [Abstract][Full Text] [Related]
44. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
Gagel RF; Costanza ME; DeLellis RA; Norton RA; Bloom SR; Miller HH; Ucci A; Nathanson L
Arch Intern Med; 1976 Dec; 136(12):1429-35. PubMed ID: 187136
[TBL] [Abstract][Full Text] [Related]
45. Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome.
Larsson LI; Schwartz T; Lundqvist G; Chance RE; Sundler F; Rehfeld JF; Grimelius L; Fahrenkrug J; Schaffalitzky de Muckadell O; Moon N
Am J Pathol; 1976 Dec; 85(3):675-84. PubMed ID: 998736
[TBL] [Abstract][Full Text] [Related]
46. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
[TBL] [Abstract][Full Text] [Related]
47. [Endocrinologic studies of tumors of Langerhans Islands].
Yamaguchi K; Abe K
Nihon Rinsho; 1980; 38(1):30-8. PubMed ID: 6248656
[No Abstract] [Full Text] [Related]
48. Radioimmunoassay for pancreatic polypeptide, and its age-related changes in concentration.
O'Hare MM; Daly JG; Buchanan KD
Clin Chem; 1983 Nov; 29(11):1923-7. PubMed ID: 6313256
[TBL] [Abstract][Full Text] [Related]
49. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.
Ichimura T; Kondo S; Okushiba S; Morikawa T; Katoh H
Int J Gastrointest Cancer; 2003; 33(2-3):99-102. PubMed ID: 14716055
[TBL] [Abstract][Full Text] [Related]
50. Pancreatic endocrine tumours associated with WDHA syndrome. An immunohistochemical and electron microscopic study.
Ooi A; Kameya T; Tsumuraya M; Yamaguchi K; Abe K; Shimosato Y; Yanaihara N
Virchows Arch A Pathol Anat Histopathol; 1985; 405(3):311-23. PubMed ID: 2579503
[TBL] [Abstract][Full Text] [Related]
51. A multihormonal tumor of the pancreas producing neurotensin associated with the WDHA syndrome. Histology, histochemistry and origin.
Bani-Sacchi T; Bartolini G; Biliotti G
Histol Histopathol; 1986 Apr; 1(2):187-95. PubMed ID: 2856535
[TBL] [Abstract][Full Text] [Related]
52. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.
Kane MG; O'Dorisio TM; Krejs GJ
N Engl J Med; 1983 Dec; 309(24):1482-5. PubMed ID: 6316136
[TBL] [Abstract][Full Text] [Related]
53. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
[TBL] [Abstract][Full Text] [Related]
54. Glucagon and VIP in the retina.
Ekman R; Tornqvist K
Invest Ophthalmol Vis Sci; 1985 Oct; 26(10):1405-9. PubMed ID: 4044167
[TBL] [Abstract][Full Text] [Related]
55. Pancreatic polypeptide-secreting islet cell tumor. A follow-up report.
Tomita T; Friesen SR; Kimmel JR
Cancer; 1986 Jan; 57(1):129-33. PubMed ID: 3000569
[TBL] [Abstract][Full Text] [Related]
56. Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
Reubi JC; Heitz PU; Gyr K
Lancet; 1987 Mar; 1(8535):741-2. PubMed ID: 2882148
[No Abstract] [Full Text] [Related]
57. Vasoactive intestinal peptide producing neuroblastoma.
Cooney DR; Voorhess ML; Fisher JE; Brecher M; Karp MP; Jewett TC
J Pediatr Surg; 1982 Dec; 17(6):821-25. PubMed ID: 6298396
[TBL] [Abstract][Full Text] [Related]
58. Biological potency of neurotensin metabolites in vivo: importance of alcohol 'fixation' of blood.
Shulkes A; Fletcher DR; Hardy KJ
J Gastroenterol Hepatol; 1989; 4(5):429-35. PubMed ID: 2491208
[TBL] [Abstract][Full Text] [Related]
59. Chronic diarrhea of infancy: nonbeta islet cell hyperplasia.
Ghishan FK; Soper RT; Nassif ED; Younoszai MK
Pediatrics; 1979 Jul; 64(1):46-9. PubMed ID: 221877
[TBL] [Abstract][Full Text] [Related]
60. Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: improvement of diarrhoea with metoclopramide.
Long RG; Bryant MG; Yuille PM; Polak JM; Bloom SR
Gut; 1981 Jun; 22(6):505-11. PubMed ID: 7021331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
